AbbVie Inc logo

AbbVie Inc Investor Relations Material

AbbVie Inc. discovers and develops pharmaceuticals worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat chronic lymphocytic leukemia (CLL), Waldenstrom's macroglobulinemia, and mantle cell lymphoma; VIEKIRA PAK, an interferon-free therapy to treat genotype 1 chronic hepatitis C virus infection in adults; TECHNIVIE for use in combination with ribavirin to treat genotype 4 chronic hepatitis C virus infection in adults without cirrhosis; VIEKIRX used with ribavirin for the treatment of genotype 1b chronic hepatitis C virus in patients without cirrhosis; and MAVYRET to treat chronic HCV genotype 1-6 infection

Upcoming events for

Q4 20222023-01-27

Latest company events

Ticker symbol

ABBV

Country

United States of America

About the company

https://www.abbvie.com

Investor Relations Page

https://investors.abbvie.com

Dig deeper into the AbbVie Inc fundamentals on Quartr.

  • Conference calls from all over the world
  • Search for anything across all transcripts
  • Consensus estimates
  • Comprehensive financial data
  • Read the transcripts or scroll the deck
  • Slide decks and earnings reports
App store link
Android play link
Quartr app screenshot